Kyle O'Hollaren

ORCID: 0009-0002-8217-7653
Publications
Citations
Views
---
Saved
---
About
Contact & Profiles
Research Areas
  • Neutrophil, Myeloperoxidase and Oxidative Mechanisms
  • Chronic Myeloid Leukemia Treatments
  • Macrophage Migration Inhibitory Factor
  • Immune Cell Function and Interaction
  • Cell Adhesion Molecules Research
  • Retinoids in leukemia and cellular processes
  • Structural Behavior of Reinforced Concrete
  • Immune cells in cancer
  • Galectins and Cancer Biology
  • Acute Myeloid Leukemia Research
  • Cytokine Signaling Pathways and Interactions
  • Cancer Immunotherapy and Biomarkers

NGM Biopharmaceuticals (United States)
2021-2024

Abstract Suppressive myeloid cells inhibit antitumor immunity by preventing T-cell responses. Immunoglobulin-like transcript 3 (ILT3; also known as LILRB4) is highly expressed on tumor-associated and promotes their suppressive phenotype. However, the ligand that engages ILT3 within tumor microenvironment renders unknown. Using a screening approach, we identified fibronectin functional for ILT3. The interaction of with polarized toward state, these effects were reversed an ILT3-specific...

10.1158/2326-6066.cir-21-0240 article EN cc-by-nc-nd Cancer Immunology Research 2021-08-23

Solid tumors are dense three-dimensional (3D) multicellular structures that enable efficient receptor-ligand trans interactions via close cell-cell contact. Immunoglobulin-like transcript (ILT)2 and ILT4 related immune-suppressive receptors play a role in the inhibition of myeloid cells within tumor microenvironment. The relative contribution ILT2 to immune context solid tissue has not been fully explored. We present evidence both contribute inhibition. found although inhibits cell...

10.1158/2326-6066.cir-23-0568 article EN Cancer Immunology Research 2024-02-23
Coming Soon ...